奥锐特药业股份有限公司 关于使用部分闲置募集资金进行现金管理到期赎回公告

Core Viewpoint - The company has approved the use of idle raised funds for cash management, allowing up to RMB 300 million to be utilized within a 12-month period [1]. Group 1 - The company held its third board meeting on August 27, 2024, where it approved the cash management proposal [1]. - The approved amount for cash management is RMB 300 million, which can be rolled over within the specified timeframe [1]. - The management team is authorized to make decisions regarding the use of these funds, with the finance department responsible for implementation [1]. Group 2 - On June 30, 2025, the company used RMB 40 million of the idle funds to purchase structured deposit products from Industrial Bank [2]. - The structured deposit product has since been redeemed [2].